Biolase, Inc.
BIOL
BIOL was delisted on the 18th of June, 2024.
26 hedge funds and large institutions have $1.42M invested in Biolase, Inc. in 2020 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 4 increasing their positions, 4 reducing their positions, and 2 closing their positions.
250% more first-time investments, than exits
New positions opened: 7 | Existing positions closed: 2
24% more funds holding
Funds holding: 21 → 26 (+5)
0% more repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 4
32% less capital invested
Capital invested by funds: $2.07M → $1.42M (-$653K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
+$125K |
| 2 |
VF
Virtu Financial
New York
|
+$96.6K |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$62.8K |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
+$10.3K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$10.3K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
-$252K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
-$88.1K |
| 3 |
Jane Street
New York
|
-$20.6K |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$11K |
| 5 |
Northern Trust
Chicago,
Illinois
|
-$5.63K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
26
Millennium Management
New York
| $4 | +$4.69K | +5 | New |
|
|
27
Renaissance Technologies
New York
| – | -$252K | -218 | Closed |
|
|
28
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| – | -$11K | -10 | Closed |
|
BIOL Hedge Fund Activity: Q3 2020 in Review
26 of the 4,956 institutional investors tracked by Wall St. Rank reported a position in Biolase, Inc. (BIOL) for Q3 2020, worth a combined $1.42M — down 32% from $2.07M a quarter earlier.
Buyers outnumbered sellers: 7 funds opened new BIOL positions and 2 closed out — a net gain of 5 holders — while 4 added to existing stakes and 4 trimmed.
The largest buyer was Sabby Management, opening a new position worth an estimated $125K. The largest seller was Renaissance Technologies, exiting entirely with an estimated $252K sold.
- 26 institutional investors held Biolase, Inc. (BIOL) as of Q3 2020, up from 21 in Q2 2020.
- Funds reported $1.42M of Biolase, Inc. stock for Q3 2020, down 32% quarter-over-quarter.
- 7 funds opened new Biolase, Inc. positions in Q3 2020 and 2 closed out, a net change of +5 holders.
- The largest Biolase, Inc. buyer in Q3 2020 was Sabby Management, an estimated $125K added.
- The largest Biolase, Inc. seller in Q3 2020 was Renaissance Technologies, an estimated $252K sold.
Based on aggregated 13F filings for Q3 2020.